Incyte ( INCY ) has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, for $1.25B. Star Therapeutics will be eligible to receive up to $750M in additional payments upon the achievement of sales milestones, for a total potential consideration of up to $2B, subject to customary closing adjustments. The proposed acquisition would add VGA0...
Incyte ( INCY ) has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, for $1.25B. Star Therapeutics will be eligible to receive up to $750M in additional payments upon the achievement of sales milestones, for a total potential consideration of up to $2B, subject to customary closing adjustments. The proposed acquisition would add VGA039, a novel monoclonal antibody, to Incyte’s hematology portfolio. VGA039 has the potential to be a universal hemostatic therapy that can treat numerous bleeding disorders, starting with all types of von Willebrand disease. The drug has advanced into a Phase 3 study designed to investigate the safety and efficacy of subcutaneous administration of VGA039 as prophylaxis for bleeding in patients with every type of von Willebrand disease. It has received fast track, orphan drug, rare pediatric disease, and breakthrough therapy designations from the U.S. Food and Drug Administration. “VGA039 fits directly into our strategy of building a top-tier growth company for the future,” said Bill Meury, CEO of Incyte. “It is a first-in-class, Phase 3 asset with compelling early data, a manageable development path and the potential to become an important new growth driver in one of our core therapeutic areas – hematology. The transaction has all of the attributes we look for in business development opportunities.” The transaction is an equity acquisition and is expected to close in the third quarter of 2026, pending Hart-Scott-Rodino review resulting in an expected R&D charge of approximately $1.25B that will be included in third quarter and full year 2026 GAAP and non-GAAP results. More on Incyte Incyte Corporation (INCY) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript Incyte Corporation (INCY) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript Incyte: Strong Business, But Risks Remain Incyte nears $2B deal for blood diso...
Volato Group ( SOAR ) has signed a definitive agreement for a $2.2M strategic equity investment. The restricted common stock placement was led by medical technology firm Catheter Precision ( VTAK ) alongside other institutional technology investors. The capital injection significantly strengthens Volato’s balance sheet following the termination of its previously announced transaction with M2i Glob...
Volato Group ( SOAR ) has signed a definitive agreement for a $2.2M strategic equity investment. The restricted common stock placement was led by medical technology firm Catheter Precision ( VTAK ) alongside other institutional technology investors. The capital injection significantly strengthens Volato’s balance sheet following the termination of its previously announced transaction with M2i Global. Management confirmed that the M2i termination will not disrupt its ability to pursue milestones under its accepted NYSE American compliance plan. The capital from this round will back Volato’s core strategic shift toward the artificial intelligence ecosystem, specifically targeting potential mergers and acquisitions (M&A) across AI software, data infrastructure, compute, and power generation sectors. Volato revealed it has already received two unsolicited, non-binding letters of intent regarding potential transactions involving AI data center infrastructure and dedicated power generation assets. The company already operates Parslee, an AI software platform specializing in document intelligence, and is actively developing Volato AI to deploy specialized AI agents into the aviation sector. Following the placement, Catheter Precision becomes Volato’s largest shareholder. The strategic investment remains subject to customary closing conditions, including the authorization of a supplemental listing application filed by Volato with the NYSE American exchange. More on Catheter Precision, Volato Group Volato Group receives NYSE American acceptance of compliance plan Volato Group uses full ATM capacity; convertible debt hits zero ahead of M2i merger Historical earnings data for Catheter Precision Financial information for Catheter Precision Financial information for Volato Group
(RTTNews) - Shares of Tate & Lyle Plc were gaining around 14 percent on the London Stock Exchange after the British sweetener and food solutions firm announced Monday its agreement to a 595 pence per share all-cash deal to be bought by U.S. food ingredients maker Ingredion Inc. T
(RTTNews) - Shares of Tate & Lyle Plc were gaining around 14 percent on the London Stock Exchange after the British sweetener and food solutions firm announced Monday its agreement to a 595 pence per share all-cash deal to be bought by U.S. food ingredients maker Ingredion Inc. T
U.S. government acquires an ownership stake in Intel (NasdaqGS:INTC) under the Trump administration. Transaction is part of a broader federal approach to take equity stakes in key AI and semiconductor companies. Move goes beyond prior grants and subsidies, introducing direct public sector participation in Intel's capital structure. Intel, traded on the NasdaqGS under the ticker INTC, is a major U....
U.S. government acquires an ownership stake in Intel (NasdaqGS:INTC) under the Trump administration. Transaction is part of a broader federal approach to take equity stakes in key AI and semiconductor companies. Move goes beyond prior grants and subsidies, introducing direct public sector participation in Intel's capital structure. Intel, traded on the NasdaqGS under the ticker INTC, is a major U.S. semiconductor and AI hardware company. Federal ownership adds a new layer to an already high...
Two Hongkongers have been sentenced to life imprisonment for murdering a man by suffocating him with tape in a village temple and burying his body under concrete outside, with a judge describing the killing as hideous “beyond words”. High Court Judge Anthony Kwok Kai-on handed down the mandatory sentences to Chan Wah-hing, 67, and Chan Yiu-lung, 33, on Monday after they were earlier convicted of m...
Two Hongkongers have been sentenced to life imprisonment for murdering a man by suffocating him with tape in a village temple and burying his body under concrete outside, with a judge describing the killing as hideous “beyond words”. High Court Judge Anthony Kwok Kai-on handed down the mandatory sentences to Chan Wah-hing, 67, and Chan Yiu-lung, 33, on Monday after they were earlier convicted of murdering a 51-year-old man over a financial dispute in September 2022 and disposing of his body near...
Luis Alvarez/DigitalVision via Getty Images Nexus Industrial REIT ( NXR.UN:CA ) is a Canadian-based REIT and publicly traded on the TSX. Back in early 2026, I wrote about this company and gave a buy recommendation. Fast forward to today, and I am changing my position to a strong buy. Management initiated this turnaround more than 2 years ago, and over the past 6 months, it has improved its finance...
Luis Alvarez/DigitalVision via Getty Images Nexus Industrial REIT ( NXR.UN:CA ) is a Canadian-based REIT and publicly traded on the TSX. Back in early 2026, I wrote about this company and gave a buy recommendation. Fast forward to today, and I am changing my position to a strong buy. Management initiated this turnaround more than 2 years ago, and over the past 6 months, it has improved its finances amid an economic slowdown. This shows the company is in good hands; if management can improve its bottom line during an economic slowdown, it can outperform in any economy. Nexus Industrial REIT's Milestones April 2026, DBRS issued a BBB investment grade rating on Nexus Industrial REIT's $500M senior unsecured debentures. The newly issued debentures are used to repay its more expensive debt. This is a credit rating improvement and lowers the overall interest costs on its debt. Q1-2026 marked the first time in 10 quarters that management was able to lower its dividend payout ratio to sub 100%. Management further reiterated its confidence that a dividend payout ratio below 100% is achievable. Same property NOI had improved to $30.0, an improvement of 2.8% 2 new industrial assets from Montreal were added to the portfolio New leasing activity resulted in 1,218,516 sf leased up with an average spread of 60% improvement over existing in-place and expiring rents Nexus Industrial REIT Stock Price Continues to be Undervalued Based on Nexus Industrial REIT's Q1-2026, its portfolio-wide cap rate is 5.94%. Using its annual dividends of $0.64, this implies its stock price should be valued at $10.77; the stock price is currently trading at $7.82, implying there is an almost $3 discount today. Looking at it through a different lens, in applying the PE ratio, Nexus Industrial REIT currently trades at a relatively cheaper ratio than the 2 other industrial competitors: Google Finance and Financial Statements One of the reasons Nexus Industrial REIT trades at a relatively large discount is ...
Croatia head coach says England game crucial to hopes Kovacic, Gvardiol and Modric lacking match sharpness Zlatko Dalic sees Croatia’s World Cup opener against England as pivotal to their summer fortunes, admitting a softer first match may have been preferable for a team struggling with form and fitness issues. Croatia beat Slovenia 2-1 in their final friendly before flying to the US but Dalic is ...
Croatia head coach says England game crucial to hopes Kovacic, Gvardiol and Modric lacking match sharpness Zlatko Dalic sees Croatia’s World Cup opener against England as pivotal to their summer fortunes, admitting a softer first match may have been preferable for a team struggling with form and fitness issues. Croatia beat Slovenia 2-1 in their final friendly before flying to the US but Dalic is likely to face several selection issues when they face England on 17 June. The Manchester City pair of Mateo Kovacic and Josip Gvardiol are both coming back from injury and it adds to the sense that Dalic’s side, who finished third in 2022 and runners-up four years earlier , risk starting their tournament on the back foot. Continue reading...
Microsoft Corporation (NASDAQ:MSFT) is one of Billionaire Ken Fisher’s Latest Portfolio: 10 Best Stocks to Buy. Technology giant Microsoft Corporation (NASDAQ:MSFT) is perhaps one of the weakest performers in Fisher Investments’ portfolio. The shares are down by 7.8% over the past year and by 9.7% year-to-date. The firm has been in the news lately following […]
Microsoft Corporation (NASDAQ:MSFT) is one of Billionaire Ken Fisher’s Latest Portfolio: 10 Best Stocks to Buy. Technology giant Microsoft Corporation (NASDAQ:MSFT) is perhaps one of the weakest performers in Fisher Investments’ portfolio. The shares are down by 7.8% over the past year and by 9.7% year-to-date. The firm has been in the news lately following […]
Guido Mieth/DigitalVision via Getty Images Introduction & Investment Thesis Despite revenue accelerating in Q1 FY26 and marking the 4th consecutive quarter of revenue growth in the 30%+ range, Shopify Inc. ( SHOP ) stock has been under quite some pressure, down 32% on a YTD basis and over 40% from its all-time highs last year. Even though the earnings report showed clear evidence that Shopify won’...
Guido Mieth/DigitalVision via Getty Images Introduction & Investment Thesis Despite revenue accelerating in Q1 FY26 and marking the 4th consecutive quarter of revenue growth in the 30%+ range, Shopify Inc. ( SHOP ) stock has been under quite some pressure, down 32% on a YTD basis and over 40% from its all-time highs last year. Even though the earnings report showed clear evidence that Shopify won’t be disrupted by Agentic AI, as GMV accelerated from growing AI-driven traffic and conversions, investors were not pleased by forward guidance. In Q2, management expects revenue to grow at a decelerated pace at a high twenties rate, which could be the result of tougher comps, while margins will also slightly compress as R&D spending on AI initiatives ramps up. This is a classic case of Wall Street short-termism affecting the stock, as I believe the growth story is fully intact. Yet, moments like these give rise to some of the best investment opportunities. In this case, I believe the risk-reward is highly attractive and will therefore continue to reiterate my “buy” rating. Q1 Marked the 4th Consecutive Quarter Of 30%+ Revenue Growth Rate Shopify reported yet another strong Q1 FY26 earnings, where revenue growth accelerated to over 34%, marking four consecutive quarters of a 30%+ growth rate. Out of the $3.17B in revenue, Merchant Solutions grew at an accelerated pace of 39%, contributing over 76% of total revenue, while Subscription revenues grew at 20% YoY, contributing the remaining 24% of revenue. Q1 FY26 Earnings Slides: Breakdown of revenue by Merchant Solutions and Subscription Solutions When it comes to Merchant Solutions, GMV grew 35% YoY with strength across geographies, merchant sizes, and channels. What was particularly interesting was that existing/older cohorts are continuing to grow their spend on the platform, with 90% of total revenue originating from merchants who have been on the platform more than a year, with merchants doing between $2M and $25M in GMV ...
lcva2/iStock Editorial via Getty Images Overview Microsoft's ( MSFT ) AI business has already surpassed a $37 billion annual revenue run rate, while Azure exceeded $75 billion in annual revenue. Yet investors remain divided over whether these gains can justify Microsoft's unprecedented AI spending spree. The debate is no longer whether Microsoft benefits from AI – it almost certainly does – but wh...
lcva2/iStock Editorial via Getty Images Overview Microsoft's ( MSFT ) AI business has already surpassed a $37 billion annual revenue run rate, while Azure exceeded $75 billion in annual revenue. Yet investors remain divided over whether these gains can justify Microsoft's unprecedented AI spending spree. The debate is no longer whether Microsoft benefits from AI – it almost certainly does – but whether the magnitude of those benefits exceeds already lofty expectations. It has experienced hefty growth driven primarily by the Azure segment, which has witnessed 40% YoY growth, and that has resulted in an overall 18.3% growth. A previous analysis stated how Azure has been the driving force for Microsoft’s growth. While Azure continues to strengthen its position as a leading cloud platform, benefitting from surging demand for AI training and inference workloads, the company is simultaneously expanding its global datacenter footprint and AI infrastructure to meet growing enterprise demand. However, what has been concerning is the relative underperformance of the other business segments. Microsoft is emerging as a foundational platform for the agentic AI era through Azure AI Foundry, Microsoft Fabric, GitHub Copilot, etc. However, even among these trends, concerns remain among elevated capital expenditure, margin pressure, and increasing competition from Amazon, Alphabet, and emerging AI-native providers. The AI race is picking up pace not only on the demand side but also in the supply side, with an increasing number of firms getting into data center development, chip manufacturing, cloud development, and so on. Microsoft still holds significant strengths due to its scale and access to resources. What remains to be seen is to understand the quantum of the bullish and bearish catalysts and understand what should be the position an investor should ideally take in such circumstances for Microsoft in their portfolio. Bullish Catalysts Azure’s Growing Strength Microsoft’s Azure...
lcva2/iStock Editorial via Getty Images Overview Microsoft's ( MSFT ) AI business has already surpassed a $37 billion annual revenue run rate, while Azure exceeded $75 billion in annual revenue. Yet investors remain divided over whether these gains can justify Microsoft's unprecedented AI spending spree. The debate is no longer whether Microsoft benefits from AI – it almost certainly does – but wh...
lcva2/iStock Editorial via Getty Images Overview Microsoft's ( MSFT ) AI business has already surpassed a $37 billion annual revenue run rate, while Azure exceeded $75 billion in annual revenue. Yet investors remain divided over whether these gains can justify Microsoft's unprecedented AI spending spree. The debate is no longer whether Microsoft benefits from AI – it almost certainly does – but whether the magnitude of those benefits exceeds already lofty expectations. It has experienced hefty growth driven primarily by the Azure segment, which has witnessed 40% YoY growth, and that has resulted in an overall 18.3% growth. A previous analysis stated how Azure has been the driving force for Microsoft’s growth. While Azure continues to strengthen its position as a leading cloud platform, benefitting from surging demand for AI training and inference workloads, the company is simultaneously expanding its global datacenter footprint and AI infrastructure to meet growing enterprise demand. However, what has been concerning is the relative underperformance of the other business segments. Microsoft is emerging as a foundational platform for the agentic AI era through Azure AI Foundry, Microsoft Fabric, GitHub Copilot, etc. However, even among these trends, concerns remain among elevated capital expenditure, margin pressure, and increasing competition from Amazon, Alphabet, and emerging AI-native providers. The AI race is picking up pace not only on the demand side but also in the supply side, with an increasing number of firms getting into data center development, chip manufacturing, cloud development, and so on. Microsoft still holds significant strengths due to its scale and access to resources. What remains to be seen is to understand the quantum of the bullish and bearish catalysts and understand what should be the position an investor should ideally take in such circumstances for Microsoft in their portfolio. Bullish Catalysts Azure’s Growing Strength Microsoft’s Azure...